ID   HNMT_HUMAN              Reviewed;         292 AA.
AC   P50135; B2R9J3; Q546Z6; Q7Z7I2; Q8IU56; Q8WW98; Q9BRW6;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   10-MAY-2017, entry version 158.
DE   RecName: Full=Histamine N-methyltransferase;
DE            Short=HMT;
DE            EC=2.1.1.8 {ECO:0000269|PubMed:26206890};
GN   Name=HNMT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=7943261;
RA   Yamauchi K., Sekizawa K., Suzuki H., Nakazawa H., Ohkawara Y.,
RA   Katayose D., Ohtsu H., Tamura G., Shibahara S., Takemura M.;
RT   "Structure and function of human histamine N-methyltransferase:
RT   critical enzyme in histamine metabolism in airway.";
RL   Am. J. Physiol. 267:L342-L349(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=8145732;
RA   Girard B., Otterness D.M., Wood T.C., Honchel R., Wieben E.D.,
RA   Weinshilboum R.M.;
RT   "Human histamine N-methyltransferase pharmacogenetics: cloning and
RT   expression of kidney cDNA.";
RL   Mol. Pharmacol. 45:461-468(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8605025; DOI=10.1006/bbrc.1996.0271;
RA   Aksoy S., Raftogianis R., Weinshilboum R.M.;
RT   "Human histamine N-methyltransferase gene: structural characterization
RT   and chromosomal location.";
RL   Biochem. Biophys. Res. Commun. 219:548-554(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Barnes W.G., Grinde E., Crawford D.R., Herrick-Davis K., Hough L.B.;
RT   "Further characterization of the histamine N-methyltransferase gene: a
RT   new mRNA species and several 3'-UTR Variants from human brain.";
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND ALTERNATIVE SPLICING.
RC   TISSUE=Brain;
RX   PubMed=14667820; DOI=10.1016/S0888-7543(03)00236-2;
RA   Barnes W.G., Grinde E., Crawford D.R., Herrick-Davis K., Hough L.B.;
RT   "Characterization of a new mRNA species from the human histamine N-
RT   methyltransferase gene.";
RL   Genomics 83:168-171(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Liver, and Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-221.
RA   Thomae B., Wieben E., Eckloff B., Weinshilboum R.M.;
RT   "Homo sapiens histamine N-methyltransferase (HNMT) gene, consensus of
RT   Coriell PDR 90.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEX WITH SUBSTRATES AND
RP   INHIBITOR.
RX   PubMed=11566133; DOI=10.1016/S0969-2126(01)00643-8;
RA   Horton J.R., Sawada K., Nishibori M., Zhang X., Cheng X.;
RT   "Two polymorphic forms of human histamine methyltransferase:
RT   structural, thermal, and kinetic comparisons.";
RL   Structure 9:837-849(2001).
RN   [14]
RP   VARIANT ILE-105, AND POLYMORPHISM.
RX   PubMed=9547362;
RA   Preuss C.V., Wood T.C., Szumlanski C.L., Raftogianis R.B.,
RA   Otterness D.M., Girard B., Scott M.C., Weinshilboum R.M.;
RT   "Human histamine N-methyltransferase pharmacogenetics: common genetic
RT   polymorphisms that alter activity.";
RL   Mol. Pharmacol. 53:708-717(1998).
RN   [15]
RP   VARIANT ILE-105, AND POLYMORPHISM.
RX   PubMed=10803682; DOI=10.1097/00008571-200004000-00007;
RA   Yan L., Galinsky R.E., Bernstein J.A., Liggett S.B.,
RA   Weinshilboum R.M.;
RT   "Histamine N-methyltransferase pharmacogenetics: association of a
RT   common functional polymorphism with asthma.";
RL   Pharmacogenetics 10:261-266(2000).
RN   [16]
RP   INVOLVEMENT IN MRT51, VARIANTS MRT51 ASP-60 AND PRO-208,
RP   CHARACTERIZATION OF VARIANTS MRT51 ASP-60 AND PRO-208, FUNCTION,
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=26206890; DOI=10.1093/hmg/ddv286;
RA   Heidari A., Tongsook C., Najafipour R., Musante L., Vasli N.,
RA   Garshasbi M., Hu H., Mittal K., McNaughton A.J., Sritharan K.,
RA   Hudson M., Stehr H., Talebi S., Moradi M., Darvish H.,
RA   Arshad Rafiq M., Mozhdehipanah H., Rashidinejad A., Samiei S.,
RA   Ghadami M., Windpassinger C., Gillessen-Kaesbach G., Tzschach A.,
RA   Ahmed I., Mikhailov A., Stavropoulos D.J., Carter M.T., Keshavarz S.,
RA   Ayub M., Najmabadi H., Liu X., Ropers H.H., Macheroux P.,
RA   Vincent J.B.;
RT   "Mutations in the histamine N-methyltransferase gene, HNMT, are
RT   associated with nonsyndromic autosomal recessive intellectual
RT   disability.";
RL   Hum. Mol. Genet. 24:5697-5710(2015).
CC   -!- FUNCTION: Inactivates histamine by N-methylation. Plays an
CC       important role in degrading histamine and in regulating the airway
CC       response to histamine. {ECO:0000269|PubMed:26206890}.
CC   -!- CATALYTIC ACTIVITY: S-adenosyl-L-methionine + histamine = S-
CC       adenosyl-L-homocysteine + N(tau)-methylhistamine.
CC       {ECO:0000255|PROSITE-ProRule:PRU00929,
CC       ECO:0000269|PubMed:26206890}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=5.47 uM for histamine (at pH 8.0 and 25 degrees Celsius)
CC         {ECO:0000269|PubMed:26206890};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:11566133}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:26206890}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P50135-1; Sequence=Displayed;
CC       Name=2; Synonyms=HNMT-S;
CC         IsoId=P50135-2; Sequence=VSP_042027;
CC         Note=Has no histamine-methylating activity.;
CC       Name=3;
CC         IsoId=P50135-3; Sequence=VSP_043482, VSP_043483;
CC         Note=No experimental confirmation available.;
CC   -!- POLYMORPHISM: Variant Ile-105 has a reduced activity and seems to
CC       be linked with a predisposition to asthma.
CC       {ECO:0000269|PubMed:10803682, ECO:0000269|PubMed:9547362}.
CC   -!- DISEASE: Mental retardation, autosomal recessive 51 (MRT51)
CC       [MIM:616739]: A form of mental retardation, a disorder
CC       characterized by significantly below average general intellectual
CC       functioning associated with impairments in adaptive behavior and
CC       manifested during the developmental period.
CC       {ECO:0000269|PubMed:26206890}. Note=The disease is caused by
CC       mutations affecting distinct genetic loci, including the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the class I-like SAM-binding
CC       methyltransferase superfamily. HNMT family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00929}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D16224; BAA03752.1; -; mRNA.
DR   EMBL; U08092; AAA17423.1; -; mRNA.
DR   EMBL; U44111; AAB18137.1; -; Genomic_DNA.
DR   EMBL; U44106; AAB18137.1; JOINED; Genomic_DNA.
DR   EMBL; U44107; AAB18137.1; JOINED; Genomic_DNA.
DR   EMBL; U44108; AAB18137.1; JOINED; Genomic_DNA.
DR   EMBL; U44109; AAB18137.1; JOINED; Genomic_DNA.
DR   EMBL; U44110; AAB18137.1; JOINED; Genomic_DNA.
DR   EMBL; AF523358; AAN33016.1; -; mRNA.
DR   EMBL; AF523359; AAN33017.1; -; mRNA.
DR   EMBL; AF523360; AAN33018.1; -; mRNA.
DR   EMBL; AF523356; AAN33014.1; -; mRNA.
DR   EMBL; AF523357; AAN33015.1; -; mRNA.
DR   EMBL; AK313804; BAG36540.1; -; mRNA.
DR   EMBL; AC093674; AAY24212.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11612.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11613.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11614.1; -; Genomic_DNA.
DR   EMBL; BC005907; AAH05907.1; -; mRNA.
DR   EMBL; BC020677; AAH20677.1; -; mRNA.
DR   EMBL; AH012839; AAP42155.1; -; Genomic_DNA.
DR   CCDS; CCDS2181.1; -. [P50135-1]
DR   CCDS; CCDS33296.1; -. [P50135-2]
DR   CCDS; CCDS33297.1; -. [P50135-3]
DR   PIR; G01409; G01409.
DR   RefSeq; NP_001019245.1; NM_001024074.2. [P50135-3]
DR   RefSeq; NP_001019246.1; NM_001024075.1. [P50135-2]
DR   RefSeq; NP_008826.1; NM_006895.2. [P50135-1]
DR   UniGene; Hs.42151; -.
DR   PDB; 1ICZ; Model; -; A=1-249.
DR   PDB; 1JQD; X-ray; 2.28 A; A/B=1-292.
DR   PDB; 1JQE; X-ray; 1.91 A; A/B=1-292.
DR   PDB; 2AOT; X-ray; 1.90 A; A/B=1-292.
DR   PDB; 2AOU; X-ray; 2.30 A; A/B=1-292.
DR   PDB; 2AOV; X-ray; 2.48 A; A/B=1-292.
DR   PDB; 2AOW; X-ray; 2.97 A; A/B=1-292.
DR   PDB; 2AOX; X-ray; 3.12 A; A/B=1-292.
DR   PDBsum; 1ICZ; -.
DR   PDBsum; 1JQD; -.
DR   PDBsum; 1JQE; -.
DR   PDBsum; 2AOT; -.
DR   PDBsum; 2AOU; -.
DR   PDBsum; 2AOV; -.
DR   PDBsum; 2AOW; -.
DR   PDBsum; 2AOX; -.
DR   ProteinModelPortal; P50135; -.
DR   SMR; P50135; -.
DR   BioGrid; 109418; 7.
DR   IntAct; P50135; 5.
DR   MINT; MINT-5001055; -.
DR   STRING; 9606.ENSP00000280097; -.
DR   BindingDB; P50135; -.
DR   ChEMBL; CHEMBL2190; -.
DR   DrugBank; DB07106; 4-(DIMETHYLAMINO)BUTYL IMIDOTHIOCARBAMATE.
DR   DrugBank; DB00613; Amodiaquine.
DR   DrugBank; DB00878; Chlorhexidine.
DR   DrugBank; DB00667; Histamine Phosphate.
DR   DrugBank; DB01103; Quinacrine.
DR   DrugBank; DB01752; S-Adenosyl-L-Homocysteine.
DR   iPTMnet; P50135; -.
DR   PhosphoSitePlus; P50135; -.
DR   BioMuta; HNMT; -.
DR   DMDM; 1708272; -.
DR   EPD; P50135; -.
DR   MaxQB; P50135; -.
DR   PaxDb; P50135; -.
DR   PeptideAtlas; P50135; -.
DR   PRIDE; P50135; -.
DR   DNASU; 3176; -.
DR   Ensembl; ENST00000280096; ENSP00000280096; ENSG00000150540. [P50135-3]
DR   Ensembl; ENST00000280097; ENSP00000280097; ENSG00000150540. [P50135-1]
DR   Ensembl; ENST00000329366; ENSP00000333259; ENSG00000150540. [P50135-2]
DR   Ensembl; ENST00000410115; ENSP00000386940; ENSG00000150540. [P50135-1]
DR   Ensembl; ENST00000475675; ENSP00000419415; ENSG00000150540. [P50135-3]
DR   GeneID; 3176; -.
DR   KEGG; hsa:3176; -.
DR   UCSC; uc002tvd.4; human. [P50135-1]
DR   CTD; 3176; -.
DR   DisGeNET; 3176; -.
DR   GeneCards; HNMT; -.
DR   HGNC; HGNC:5028; HNMT.
DR   HPA; HPA035480; -.
DR   HPA; HPA035481; -.
DR   MalaCards; HNMT; -.
DR   MIM; 605238; gene.
DR   MIM; 616739; phenotype.
DR   neXtProt; NX_P50135; -.
DR   OpenTargets; ENSG00000150540; -.
DR   PharmGKB; PA190; -.
DR   eggNOG; ENOG410IGS0; Eukaryota.
DR   eggNOG; ENOG410ZU1D; LUCA.
DR   GeneTree; ENSGT00390000002862; -.
DR   HOGENOM; HOG000231790; -.
DR   HOVERGEN; HBG051914; -.
DR   InParanoid; P50135; -.
DR   KO; K00546; -.
DR   OMA; MDISDCF; -.
DR   OrthoDB; EOG091G0DY6; -.
DR   PhylomeDB; P50135; -.
DR   TreeFam; TF331080; -.
DR   BioCyc; MetaCyc:HS07674-MONOMER; -.
DR   BRENDA; 2.1.1.8; 2681.
DR   Reactome; R-HSA-2408508; Metabolism of ingested SeMet, Sec, MeSec into H2Se.
DR   Reactome; R-HSA-70921; Histidine catabolism.
DR   EvolutionaryTrace; P50135; -.
DR   GenomeRNAi; 3176; -.
DR   PRO; PR:P50135; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000150540; -.
DR   CleanEx; HS_HNMT; -.
DR   Genevisible; P50135; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0046539; F:histamine N-methyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0007420; P:brain development; IBA:GO_Central.
DR   GO; GO:0001695; P:histamine catabolic process; IDA:UniProtKB.
DR   GO; GO:0006548; P:histidine catabolic process; TAS:Reactome.
DR   GO; GO:0006972; P:hyperosmotic response; IEA:Ensembl.
DR   GO; GO:0032259; P:methylation; IDA:UniProtKB.
DR   GO; GO:1903955; P:positive regulation of protein targeting to mitochondrion; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0007585; P:respiratory gaseous exchange; TAS:ProtInc.
DR   GO; GO:0014075; P:response to amine; IEA:Ensembl.
DR   GO; GO:0042220; P:response to cocaine; IEA:Ensembl.
DR   GO; GO:0051384; P:response to glucocorticoid; IEA:Ensembl.
DR   GO; GO:0035902; P:response to immobilization stress; IEA:Ensembl.
DR   GO; GO:0070555; P:response to interleukin-1; IEA:Ensembl.
DR   GO; GO:0002347; P:response to tumor cell; IEA:Ensembl.
DR   InterPro; IPR016673; HHMT-like.
DR   InterPro; IPR029063; SAM-dependent_MTases.
DR   PIRSF; PIRSF016616; HHMT; 1.
DR   SUPFAM; SSF53335; SSF53335; 1.
DR   PROSITE; PS51597; SAM_HNMT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Disease mutation; Mental retardation; Methyltransferase; Polymorphism;
KW   Reference proteome; S-adenosyl-L-methionine; Transferase.
FT   CHAIN         1    292       Histamine N-methyltransferase.
FT                                /FTId=PRO_0000084021.
FT   BINDING      28     28       Substrate.
FT   BINDING      60     60       S-adenosyl-L-methionine; via carbonyl
FT                                oxygen.
FT   BINDING      89     89       S-adenosyl-L-methionine.
FT   BINDING      94     94       S-adenosyl-L-methionine.
FT   BINDING     120    120       S-adenosyl-L-methionine; via amide
FT                                nitrogen.
FT   BINDING     142    142       S-adenosyl-L-methionine; via carbonyl
FT                                oxygen.
FT   BINDING     283    283       Substrate.
FT   VAR_SEQ      47     51       IGDTK -> YQNCC (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043482.
FT   VAR_SEQ      52    292       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043483.
FT   VAR_SEQ      64    292       GEIDLQILSKVQAQYPGVCINNEVVEPSAEQIAKYKELVAK
FT                                TSNLENVKFAWHKETSSEYQSRMLEKKELQKWDFIHMIQML
FT                                YYVKDIPATLKFFHSLLGTNAKMLIIVVSGSSGWDKLWKKY
FT                                GSRFPQDDLCQYITSDDLTQMLDNLGLKYECYDLLSTMDIS
FT                                DCFIDGNENGDLLWDFLTETCNFNATAPPDLRAELGKDLQE
FT                                PEFSAKKEGKVLFNNTLSFIVIEA -> DCLIRGSSRVLKR
FT                                NSCFILCSTRQKDKPGMRIHDERSSELPFGAARLESKSAFP
FT                                SFLVSFILF (in isoform 2).
FT                                {ECO:0000303|PubMed:14667820}.
FT                                /FTId=VSP_042027.
FT   VARIANT      60     60       G -> D (in MRT51; no effect on protein
FT                                abundance; no effect on protein
FT                                localization to the cytoplasm; decreased
FT                                thermal stability; decreased ligand
FT                                affinity for S-adenosyl-L-methionine;
FT                                loss of histamine N-methyltransferase
FT                                activity; dbSNP:rs758252808).
FT                                {ECO:0000269|PubMed:26206890}.
FT                                /FTId=VAR_076312.
FT   VARIANT     105    105       T -> I (in dbSNP:rs1801105).
FT                                {ECO:0000269|PubMed:10803682,
FT                                ECO:0000269|PubMed:9547362}.
FT                                /FTId=VAR_010252.
FT   VARIANT     208    208       L -> P (in MRT51; loss of protein
FT                                solubility; increased aggregation in the
FT                                cytoplasm; dbSNP:rs745756308).
FT                                {ECO:0000269|PubMed:26206890}.
FT                                /FTId=VAR_076313.
FT   CONFLICT    199    199       I -> V (in Ref. 1; BAA03752).
FT                                {ECO:0000305}.
FT   CONFLICT    234    234       N -> D (in Ref. 9; AAH20677).
FT                                {ECO:0000305}.
FT   HELIX         8     10       {ECO:0000244|PDB:2AOT}.
FT   HELIX        12     23       {ECO:0000244|PDB:2AOT}.
FT   HELIX        28     38       {ECO:0000244|PDB:2AOT}.
FT   HELIX        40     43       {ECO:0000244|PDB:2AOT}.
FT   STRAND       44     46       {ECO:0000244|PDB:2AOT}.
FT   TURN         47     50       {ECO:0000244|PDB:2AOT}.
FT   STRAND       52     60       {ECO:0000244|PDB:2AOT}.
FT   HELIX        65     77       {ECO:0000244|PDB:2AOT}.
FT   STRAND       82     88       {ECO:0000244|PDB:2AOT}.
FT   HELIX        92    103       {ECO:0000244|PDB:2AOT}.
FT   STRAND      111    116       {ECO:0000244|PDB:2AOT}.
FT   HELIX       120    128       {ECO:0000244|PDB:2AOT}.
FT   TURN        129    131       {ECO:0000244|PDB:2AOT}.
FT   STRAND      136    143       {ECO:0000244|PDB:2AOT}.
FT   HELIX       145    147       {ECO:0000244|PDB:2AOT}.
FT   HELIX       151    160       {ECO:0000244|PDB:2AOT}.
FT   STRAND      162    173       {ECO:0000244|PDB:2AOT}.
FT   STRAND      175    177       {ECO:0000244|PDB:2AOW}.
FT   HELIX       178    186       {ECO:0000244|PDB:2AOT}.
FT   HELIX       187    189       {ECO:0000244|PDB:2AOT}.
FT   HELIX       201    211       {ECO:0000244|PDB:2AOT}.
FT   STRAND      215    220       {ECO:0000244|PDB:2AOT}.
FT   STRAND      223    225       {ECO:0000244|PDB:2AOT}.
FT   HELIX       227    230       {ECO:0000244|PDB:2AOT}.
FT   HELIX       235    245       {ECO:0000244|PDB:2AOT}.
FT   STRAND      247    249       {ECO:0000244|PDB:2AOT}.
FT   HELIX       250    253       {ECO:0000244|PDB:2AOT}.
FT   HELIX       256    265       {ECO:0000244|PDB:2AOT}.
FT   TURN        269    271       {ECO:0000244|PDB:2AOT}.
FT   STRAND      272    275       {ECO:0000244|PDB:2AOT}.
FT   STRAND      278    282       {ECO:0000244|PDB:2AOT}.
FT   STRAND      285    291       {ECO:0000244|PDB:2AOT}.
SQ   SEQUENCE   292 AA;  33295 MW;  9CCADD1EE0CCB653 CRC64;
     MASSMRSLFS DHGKYVESFR RFLNHSTEHQ CMQEFMDKKL PGIIGRIGDT KSEIKILSIG
     GGAGEIDLQI LSKVQAQYPG VCINNEVVEP SAEQIAKYKE LVAKTSNLEN VKFAWHKETS
     SEYQSRMLEK KELQKWDFIH MIQMLYYVKD IPATLKFFHS LLGTNAKMLI IVVSGSSGWD
     KLWKKYGSRF PQDDLCQYIT SDDLTQMLDN LGLKYECYDL LSTMDISDCF IDGNENGDLL
     WDFLTETCNF NATAPPDLRA ELGKDLQEPE FSAKKEGKVL FNNTLSFIVI EA
//
